Paget's disease of bone
From Wikipedia, the free encyclopedia
| Paget's disease of bone | |
| Classification and external resources | |
| "This 92 year-old male patient presented for assessment of acute hemiparesis. An incidental finding was marked thickening of the calvarium. The diploic space is widened and there are ill-defined sclerotic and lucent areas throughout. The cortex is thickened and irregular. The findings probably correspond to the “cotton wool spots” seen on plain films in the later stages of Paget’s disease." (dr Dawes) | |
| ICD-10 | M88. |
| ICD-9 | 731.0 |
| OMIM | 602080 |
| DiseasesDB | 9479 |
| MedlinePlus | 000414 |
| eMedicine | med/2998 radio/514 pmr/98 |
| MeSH | D010001 |
Paget's disease, otherwise known as osteitis deformans, is a chronic disorder that typically results in enlarged and deformed bones.[1] It is named after Sir James Paget, the British surgeon who first described this disease in 1877.[2]. The excessive breakdown and formation of bone tissue that occurs with Paget's disease can cause bone to weaken, resulting in bone pain, arthritis, deformities, and fractures.
Paget's disease is rarely diagnosed in people less than 40 years of age. Men are more commonly affected than women. Prevalence of Paget's disease ranges from 1.5 to 8 percent depending on age and country of residence. Prevalence of familial Paget's disease (where more than one family member has the disease) ranges from 10 to 40 percent in different parts of the world.[citations needed]Because early diagnosis and treatment is important, after age 40, siblings and children of someone with Paget's disease may wish to have an alkaline phosphatase blood test every two or three years. If the alkaline phosphatase level is above normal, other tests such as a bone-specific alkaline phosphatase test, bone scan, or x-ray can be performed.
Contents |
[edit] Causes
[edit] Viral
Paget's disease may be caused by a slow virus infection (i.e., paramyxoviruses) present for many years before symptoms appear. Candidates include:
It has been suggested that contamination may have played a role in producing past positive results.[9]
[edit] Genetic
There is also a hereditary factor.[10][11] Associations include:
| Name | OMIM | Locus | Gene |
|---|---|---|---|
| PDB1 | 167250 | 6p | ? |
| PDB2 | 18q22.1 | RANK | |
| PDB3 | 5q35 | SQSTM1 | |
| PDB4 | 606263 | 5q31[12] | ? |
[edit] Pathogenesis
The pathogenesis (process of how a disease develops) of Paget's disease is described in 3 stages which are: i. Osteoclastic activity ii. Mixed osteoclastic-osteoblastic activity iii. Exhaustive (burnt out) stage
Sir James Paget first thought that the disease was due to an inflammatory process. New evidence suggests that he might be right and that a paramyxovirus infection is the underlying cause of Pagets Disease. However no infectuous virus has yet been isolated and other evidence suggests that an intrinsical hyperresponsive reaction to Vitamin D and RANK ligand is the cause. Further research is therefore nessecary. [13]
[edit] Symptoms
Many patients do not know they have Paget's disease because they have a mild case with no symptoms. Sometimes, symptoms may be confused with those of arthritis or other disorders. In other cases, the diagnosis is made only after complications have developed. Symptoms can include:
- Bone pain is the most common symptom. Bone pain can occur in any bone affected by Paget's disease. It often localizes to areas adjacent to the joints.
- Headaches and hearing loss may occur when Paget's disease affects the skull.
- Pressure on nerves may occur when Paget's disease affects the skull or spine.
- Somnolence (drowsiness) due to vascular steal syndrome of the skull.
- Paralysis due to vascular steal syndrome of the vertebrae.
- Increased head size, bowing of limb, or curvature of spine may occur in advanced cases.
- Hip pain may occur when Paget's disease affects the pelvis or thighbone.
- Damage to joint cartilage may lead to arthritis.
- Teeth may spread intraorally - due to the intra-oral force placed on the anterior teeth (especially maxillary central and lateral incisors) by the labial tissues, especially the muscles.
- Chalkstick fractures.
- Mosaic bone pattern
[edit] Diagnosis
Paget's disease may be diagnosed using one or more of the following tests:
- Pagetic bone has a characteristic appearance on x-rays. A skeletal survey is therefore indicated.
- An elevated level of alkaline phosphatase in the blood in combination with normal calcium, phosphate, and aminotransferase levels in an elderly patient are suggestive of Paget's disease.
- Bone scans are useful in determining the extent and activity of the condition. If a bone scan suggests Paget's disease, the affected bone(s) should be x-rayed to confirm the diagnosis.
[edit] Prognosis
The outlook is generally good, particularly if treatment is given before major changes in the affected bones have occurred. Any bone or bones can be affected, but Paget's disease occurs most frequently in the spine, skull, pelvis, thighs, and lower legs. In general, symptoms progress slowly, and the disease does not spread to normal bones. Treatment can control Paget's disease and lessen symptoms but is not a cure. Osteogenic sarcoma, a form of bone cancer, is an extremely rare complication that occurs in less than one percent of all patients.
[edit] Other medical conditions
Paget's disease may lead to other medical conditions, including:
- Arthritis: Long bones in the leg may bow, distorting alignment and increasing pressure on nearby joints. In addition, Pagetic bone may enlarge, causing joint surfaces to undergo excessive wear and tear. In these cases, pain may be due to a combination of Paget's disease and osteoarthritis.
- Loss of hearing in one or both ears may occur when Paget's disease affects the skull and the bone that surrounds the inner ear. Treating the Paget's disease may slow or stop hearing loss. Hearing aids may also help. It is believed by some that the disease was responsible for Beethoven's deafness.[citation needed]
- Cardiovascular disease: In severe Paget's disease (i.e. with more than 15% skeletal involvement), AV connections often form in the bone, and so the heart has to work harder (pump more blood) to ensure adequate oxygen supply to the tissues. This increase in cardiac output can lead to calcification of the aortic valve and the resulting aortic stenosis causes left ventricular hypertrophy and eventually high-output congestive failure.
- Kidney stones are somewhat more common in patients with Paget's disease.
- Nervous system: Pagetic bone can cause pressure on the brain, spinal cord, or nerves, and reduced blood flow to the brain and spinal cord.
- Sarcoma: Rarely, Paget's disease is associated with the development of a malignant tumor of bone. When there is a sudden onset or worsening of pain, sarcoma should be considered.
- When Paget's disease affects the facial bones, the teeth may become loose. Disturbance in chewing may occur.
- Rarely, when the skull is involved, the nerves to the eye may be affected, causing some loss of vision.
it also associated with angioid retinal streaks Paget's disease is not associated with osteoporosis. Although Paget's disease and osteoporosis can occur in the same patient, they are different disorders. Despite their marked differences, several treatments for Paget's disease are also used to treat osteoporosis.
[edit] Treatment
[edit] Types of physicians
The following types of medical specialists are generally knowledgeable about treating Paget's disease.
- Endocrinologists -- Internists who specialize in hormonal and metabolic disorders.
- Rheumatologists -- Internists who specialize in joint and muscle disorders.
- Specialists -- Orthopedic surgeons, neurologists, and otolaryngologists may be called upon to evaluate specialized symptoms.
[edit] Drug therapy
The goal of treatment is to relieve bone pain and prevent the progression of the disease. The U.S. Food and Drug Administration has approved the following treatments for Paget's disease:
[edit] Bisphosphonates
Five bisphosphonates are currently available. In general, the most commonly prescribed are the three most potent bisphosphonates: Actonel, Fosamax and Aredia. Didronel and Skelid may be appropriate therapies for selected patients but are less commonly used. As a rule, bisphosphonate tablets should be taken with 6–8 oz of tap water (not from a source with high mineral content) on an empty stomach. None of these drugs should be used by people with severe kidney disease.
- Didronel (etidronate disodium) -- Tablet; approved regimen is 200–400 mg once daily for 6 months; the higher dose (400 mg) is more commonly used; no food, beverages, or medications for 2 hours before and after taking; course should not exceed 6 months, but repeat courses can be given after rest periods, preferably of 3–6 months duration.
- Aredia (pamidronate disodium) -- Intravenous; approved regimen 30 mg infusion over 4 hours on 3 consecutive days; more commonly used regimen 60 mg over 2–4 hours for 2 or more consecutive or non-consecutive days.
- Fosamax (alendronate sodium) -- Tablet; 40 mg once daily for 6 months; patients should wait at least 30 minutes after taking before eating any food, drinking anything other than tap water, taking any medication, or lying down (patient may sit).
- Skelid (tiludronate disodium) -- Tablet; 400 mg (two 200 mg tablets) once daily for 3 months; may be taken any time of day, as long as there is a period of 2 hours before and after resuming food, beverages, and medications.
- Actonel (risedronate sodium) -- Tablet; 30 mg once daily for 2 months; patients should wait at least 30 minutes after taking before eating any food, drinking anything other than tap water, taking any medication, or lying down (patient may sit).
- Reclast (Aclasta) (zoledronic acid) -- intravenous infusion; one single dose (5 mg over 15 min), effective for 2 years.
[edit] Calcitonin
- Miacalcin is administered by injection; 50 to 100 units daily or 3 times per week for 6–18 months. Repeat courses can be given after brief rest periods. Miacalcin may be appropriate for certain patients but is seldom used. The nasal spray form of this drug is not approved for the treatment of Paget's disease.
[edit] Surgery
Medical therapy prior to surgery helps to decrease bleeding and other complications. Patients who are having surgery should discuss pre-treatment with their physician. There are generally three major complications of Paget's disease for which surgery may be recommended.
- Fractures—Surgery may allow fractures to heal in better position.
- Severe degenerative arthritis—If disability is severe and medication and physical therapy are no longer helpful, joint replacement of the hips and knees may be considered.
- Bone deformity—Cutting and realignment of Pagetic bone (osteotomy) may help painful weight bearing joints, especially the knees.
Complications resulting from enlargement of the skull or spine may injure the nervous system. However, most neurologic symptoms, even those that are moderately severe, can be treated with medication and do not require neurosurgery.
[edit] Diet and Exercise
In general, patients with Paget's disease should receive 1000-1500 mg of calcium, adequate sunshine, and at least 400 units of vitamin D daily. This is especially important in patients being treated with bisphosphonates. Patients with a history of kidney stones should discuss calcium and vitamin D intake with their physician.
Exercise is very important in maintaining skeletal health, avoiding weight gain, and maintaining joint mobility. Since undue stress on affected bones should be avoided, patients should discuss any exercise program with their physician before beginning.
[edit] Reference In Pop Culture
C.S.I. New York-Murder victim in Season 2 episode "Youngblood" was afflicted with Pagets disease. Retired Boston Red Sox centerfielder Dominic DiMaggio suffers from Paget's Disease. Dom DiMaggio has served as a member of the board of directors of the Paget Foundation. http://www.paget.org/Paget25thBook-ForWeb.pdf
[edit] References
- ^ osteitis deformans at Dorland's Medical Dictionary
- ^ Paget J., On a form of chronic inflammation of bones (osteitis deformans), Trans Med-Chir Soc, 1877,60,37:63
- ^ Friedrichs WE, Reddy SV, Bruder JM, et al. (January 2002). "Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease". J. Bone Miner. Res. 17 (1): 145–51. doi:. PMID 11771661.
- ^ Baslé MF, Fournier JG, Rozenblatt S, Rebel A, Bouteille M (May 1986). "Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization". J. Gen. Virol. 67 ( Pt 5): 907–13. PMID 3701300. http://vir.sgmjournals.org/cgi/pmidlookup?view=long&pmid=3701300.
- ^ Matthews BG, Afzal MA, Minor PD, et al. (April 2008). "Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease". J. Clin. Endocrinol. Metab. 93 (4): 1398–401. doi:. PMID 18230662. http://jcem.endojournals.org/cgi/pmidlookup?view=long&pmid=18230662.
- ^ Hoyland JA, Dixon JA, Berry JL, Davies M, Selby PL, Mee AP (May 2003). "A comparison of in situ hybridisation, reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ-RT-PCR for the detection of canine distemper virus RNA in Paget's disease". J. Virol. Methods 109 (2): 253–9. PMID 12711070. http://linkinghub.elsevier.com/retrieve/pii/S016609340300079X.
- ^ Gordon MT, Anderson DC, Sharpe PT (1991). "Canine distemper virus localised in bone cells of patients with Paget's disease". Bone 12 (3): 195–201. doi:. PMID 1910961.
- ^ Mills BG, Singer FR, Weiner LP, Holst PA (February 1981). "Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone". Proc. Natl. Acad. Sci. U.S.A. 78 (2): 1209–13. PMID 6940136.
- ^ Ralston SH, Afzal MA, Helfrich MH, et al. (April 2007). "Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone". J. Bone Miner. Res. 22 (4): 569–77. doi:. PMID 17227218. http://www.jbmronline.com/doi/abs/10.1359/jbmr.070103?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov.
- ^ Ralston SH, Langston AL, Reid IR (July 2008). "Pathogenesis and management of Paget's disease of bone". Lancet 372 (9633): 155–63. doi:. PMID 18620951. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(08)61035-1.
- ^ Whyte MP (April 2006). "Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling". Ann. N. Y. Acad. Sci. 1068: 143–64. doi:. PMID 16831914. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0077-8923&date=2006&volume=1068&spage=143.
- ^ Laurin N, Brown JP, Lemainque A, et al. (September 2001). "Paget disease of bone: mapping of two loci at 5q35-qter and 5q31". Am. J. Hum. Genet. 69 (3): 528–43. doi:. PMID 11473345. PMC: 1235483. http://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)61164-1.
- ^ Basic Pathology, Kumar Abbas Fausto Mitchell, Saunders Elsevier
|
||||||||||||||||||||||||||||||||||||||||||||||

